O	0	1	[
O	1	11	Preventing
B-condition	12	23	lymphoedema
O	24	29	after
O	30	36	breast
O	37	43	cancer
O	44	51	surgery
O	52	54	by
B-intervention	55	62	elastic
I-intervention	63	72	restraint
I-intervention	73	81	orthotic
I-intervention	82	85	and
I-intervention	86	92	manual
I-intervention	93	102	lymphatic
I-intervention	103	111	drainage
O	111	112	:
O	113	114	a
O	115	125	randomized
O	126	134	clinical
O	135	140	trial
O	140	141	]
O	141	142	.

O	143	152	Secondary
O	153	164	lymphoedema
O	165	167	is
O	168	178	considered
O	179	182	one
O	183	185	of
O	186	189	the
O	190	194	most
O	195	201	common
O	202	215	complications
O	216	221	after
O	222	228	breast
O	229	235	cancer
O	236	243	surgery
O	243	244	.

O	245	248	The
O	249	252	aim
O	253	255	of
O	256	259	the
O	260	267	present
O	268	273	study
O	274	277	was
O	278	280	to
O	281	288	analyze
O	289	292	the
O	293	306	effectiveness
O	307	309	of
O	310	321	containment
O	322	329	elastic
O	330	338	orthosis
O	339	342	and
O	343	349	manual
O	350	359	lymphatic
O	360	368	drainage
O	369	371	in
O	372	375	the
O	376	386	prevention
O	387	389	of
O	390	401	lymphoedema
O	402	411	secondary
O	412	414	to
O	415	425	mastectomy
O	425	426	.

O	427	429	An
O	430	442	experimental
O	443	448	study
O	449	452	was
O	453	462	performed
O	463	467	with
O	468	469	a
O	470	477	control
O	478	483	group
O	483	484	.

B-total-participants	485	490	Forty
I-total-participants	490	491	-
I-total-participants	491	496	eight
O	497	505	patients
O	506	510	were
O	511	519	randomly
O	520	528	assigned
O	529	531	to
O	532	544	experimental
O	545	546	(
O	546	557	containment
O	558	565	elastic
O	566	574	orthosis
O	575	578	and
O	579	585	manual
O	586	595	lymphatic
O	596	604	drainage
O	604	605	)
O	606	609	and
B-control	610	617	control
I-control	618	619	(
I-control	619	627	postural
I-control	628	636	measures
I-control	636	637	)
O	638	644	groups
O	644	645	.

O	646	654	Outcomes
O	655	663	measures
O	664	668	were
B-outcome-Measure	669	676	quality
I-outcome-Measure	677	679	of
I-outcome-Measure	680	684	life
O	684	685	,
B-outcome-Measure	686	690	body
I-outcome-Measure	691	702	composition
O	702	703	,
B-outcome-Measure	704	715	temperature
O	715	716	,
B-outcome-Measure	717	727	functional
I-outcome-Measure	728	738	assessment
I-outcome-Measure	739	741	of
I-outcome-Measure	742	745	the
I-outcome-Measure	746	754	shoulder
O	754	755	,
B-outcome-Measure	756	760	pain
O	761	764	and
B-outcome-Measure	765	769	limb
I-outcome-Measure	770	776	volume
O	776	777	.

O	778	786	Measures
O	787	791	were
O	792	801	performed
O	802	804	at
O	805	813	baseline
O	814	817	and
O	818	823	after
O	824	825	8
O	825	826	-
O	826	832	months
O	833	845	intervention
O	845	846	.

O	847	852	After
O	853	856	the
O	857	869	intervention
O	870	876	period
O	876	877	,
O	878	881	the
O	882	894	experimental
O	895	900	group
O	901	907	showed
O	908	919	significant
O	920	931	differences
O	932	933	(
O	933	934	P
O	934	935	<
O	935	936	.
O	936	938	05
O	938	939	)
O	940	942	in
O	943	946	the
B-outcome	947	954	quality
I-outcome	955	957	of
I-outcome	958	962	life
O	962	963	,
B-outcome	964	977	extracellular
I-outcome	978	983	water
O	983	984	,
O	985	988	and
B-outcome	989	999	functional
I-outcome	1000	1010	assessment
I-outcome	1011	1013	of
I-outcome	1014	1017	the
I-outcome	1018	1024	volume
I-outcome	1025	1027	of
I-outcome	1028	1031	the
I-outcome	1032	1036	limb
O	1037	1039	of
O	1040	1043	the
O	1044	1057	mastectomized
O	1058	1062	side
O	1062	1063	.

O	1064	1067	The
O	1068	1079	application
O	1080	1082	of
O	1083	1094	containment
O	1095	1102	elastic
O	1103	1111	orthosis
O	1112	1115	and
O	1116	1122	manual
O	1123	1132	lymphatic
O	1133	1141	drainage
O	1142	1152	contribute
O	1153	1155	to
O	1156	1163	prevent
O	1164	1173	secondary
O	1174	1185	lymphoedema
O	1186	1191	after
O	1192	1198	breast
O	1199	1205	cancer
O	1206	1213	surgery
O	1213	1214	,
O	1215	1224	improving
O	1225	1228	the
O	1229	1236	quality
O	1237	1239	of
O	1240	1244	life
O	1245	1247	in
O	1248	1253	these
O	1254	1262	patients
O	1262	1263	.
